Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $4.47B.
ENTERPRISE VALUE (EV)
$4.47B
Definium Therapeutics, Inc.
Market Cap
$4.73B
Enterprise Value (EV)
$4.47B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $4.73B | $4.47B |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | $4.67B |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | $5.73B |
| BillionToOne, Inc. (BLLN)vs › | $4.61B | $4.20B |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.86B | $4.59B |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | $4.75B |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | $5.33B |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | $4.69B |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | $4.71B |
| Erasca, Inc. (ERAS)vs › | $5.08B | $5.08B |
Market Cap
$4.73B
Total Debt
$0.00
Cash
$257.84M
Enterprise Value
$4.47B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
